Highly selective HealthTech-focused Mature startups

HealthTech Acceleration
Select Program

A selective program for European Health Tech startups seeking stronger market readiness, sharper investor positioning, and tailored execution support.

Designed for fit,
not volume

What the program combines

  • Capital access
  • Health Sector expertise
  • Tailored growth support

Who this program is built for

Designed for a small number of mature European Health Tech startups that are beyond generic incubation and need sharper healthcare market traction, execution support, and a credible path toward financing.

Not for very early-stage projects, generic incubation needs, or research-only initiatives.

Healthcare relevance

Startups addressing a real healthcare use case, with clear relevance for providers, payers, industry players, or stakeholders.

Maturity & readiness

A developed solution, early field validation, and sufficient regulatory or clinical maturity to benefit from operational support.

Defensibility & deployment

Credible differentiation, IP defensibility, and a realistic path toward adoption or deployment beyond the pilot stage.

Execution & investor fit

Teams with real execution capacity, a credible financing path, and a profile compatible with investment-backed support.

What selected startups actually unlock

Built to help mature HealthTech startups turn traction potential into healthcare-market progress. A selective combination of access, acceleration, and capital.

Strategic healthcare access

Targeted introductions to the right providers, payers, healthcare operators, industrial partners, and ecosystem stakeholders to accelerate real market opportunities.

Market acceleration

Sharper go-to-market priorities, clearer target accounts, and actionable pathways to adoption, reimbursement, and deployment.

Financing leverage

A clear pathway combining initial capital, public-funding opportunities, and selective exposure to relevant investors.

Deployment support

Support to move beyond the pilot stage and structure credible deployment pathways across care settings and target markets.

Concrete outcomes

A stronger healthcare market roadmap, relevant strategic introductions, and a credible path toward post-program growth.

Investment flow and allocation

Up to €200k

At onboarding

€150k

Later release

€50k *

Follow-on potential

Up to €2M

Transparent structure

€75k available at entry + €50k later = up to €125k total potential immediate operating cash.

*Subject to predefined KPIs

Program architecture

A selective structure built around one intensive core phase and lighter follow-up.

1
Phase 1 • 4 months

Intensive Program

A focused operational phase designed to accelerate Health Tech market access, sharpen commercial priorities, and strengthen financing readiness.

2
Phase 2 • Post-program

Implementation follow-up

A follow-up phase to support execution on key milestones, maintain momentum, and advance the most relevant next-step priorities.

Phase 1 Breakdown

Intensive Program

A four-month operational phase designed to remove growth barriers and accelerate market-facing execution.

Identify the main blockers across market access, regulatory and clinical readiness, deployment readiness, financing logic, and execution priorities.

Pain points addressed
  • Unclear healthcare market barriers
  • Weak market prioritization
  • Unclear next-step roadmap
  • Gaps in operational readiness
Expected results
Clear diagnostic Prioritized roadmap Milestone framework

Refine target accounts, commercial priorities, adoption pathway, reimbursement or willingness-to-pay logic.

Pain points addressed
  • Unclear buyer mapping
  • Pricing uncertainty
  • Diffuse commercial focus
  • Unclear route to market
Expected results
Target stakeholder map Clearer commercial path Stronger pricing logic

Work on strategic introductions, healthcare partnerships, and the most relevant execution priorities across market access, clinical adoption, and deployment.

Pain points addressed
  • Limited strategic access
  • Weak partnership pipeline
  • Insufficient external momentum
  • Weak financing leverage
Expected results
Opportunity pipeline Prioritized introductions Clearer funding path

Consolidate progress, clarify the roadmap for scale-up, financing, and expansion in target healthcare environments.

Pain points addressed
  • Difficulty moving beyond pilot
  • Weak deployment planning
  • Lack of scale-up roadmap
  • Unclear post-program priorities
Expected results
Deployment roadmap Financing prioritization Credible expansion path
Phase 2 Breakdown

Implementation follow-up

A follow-up phase to support execution on key milestones, maintain momentum, and advance the most relevant next-step priorities across business development, deployment, governance, and financing.

Business development
Deployment follow-up
Governance & board

Built for the right HealthTech startups

Startups with real maturity, real ambition, and a credible path toward market and investor readiness.

Submit your application

* Selection remains based on overall fit, maturity, and execution potential.